{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:24Z","timestamp":1790622324530,"version":"4.1.0"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuropharm.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T16:00:33Z","timestamp":1499875233000},"page":"50-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Antagonism of the 5-HT 6 receptor \u2013 Preclinical rationale for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"125","author":[{"given":"Inge E.M.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"M\u00f8rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.07.010_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2014.08.015","article-title":"Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential","volume":"86","author":"Ahnaou","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1471-4159.1984.tb00913.x","article-title":"Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia","volume":"43","author":"Arai","year":"1984","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145710000659","article-title":"Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats","volume":"13","author":"Arnt","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib4","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1523\/JNEUROSCI.0115-12.2012","article-title":"Prolonged disynaptic inhibition in the cortex mediated by slow, non-alpha7 nicotinic excitation of a specific subset of cortical interneurons","volume":"32","author":"Arroyo","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuropharm.2015.03.032","article-title":"Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT(6) receptors in the dorsal raphe nucleus","volume":"95","author":"Asaoka","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.clinph.2012.09.017","article-title":"Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients","volume":"124","author":"Babiloni","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0304-3940(89)90709-X","article-title":"Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata","volume":"100","author":"Baker","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-7020-5307-8.00002-8","article-title":"Brain's alpha, beta, gamma, delta, and theta oscillations in neuropsychiatric diseases: proposal for biomarker strategies","volume":"62","author":"Basar","year":"2013","journal-title":"Suppl.\u00a0Clin.Neurophysiol"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib9","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1021\/jm5003952","article-title":"Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease","volume":"57","author":"Benhamu","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib10","first-page":"CD001190","article-title":"Donepezil for dementia due to Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane. Database. Syst. Rev."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(86)90019-5","article-title":"The physiology and pharmacology of hippocampal formation theta rhythms","volume":"26","author":"Bland","year":"1986","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0896-6273(03)00300-3","article-title":"A\u00a0novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex","volume":"38","author":"Blatow","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib13","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.npp.1301294","article-title":"Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors","volume":"32","author":"Bonsi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0269881115573804","article-title":"Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain","volume":"29","author":"Borsini","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0223-5234(00)01209-5","article-title":"5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides","volume":"36","author":"Bos","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-3565(25)10539-9","article-title":"Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides","volume":"274","author":"Bourson","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1471-4159.1983.tb11838.x","article-title":"Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease","volume":"41","author":"Bowen","year":"1983","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.5b00061","article-title":"Pharmacological evidence for 5-HT6 receptor modulation of 5-HT neuron firing in\u00a0vivo","volume":"6","author":"Brouard","year":"2015","journal-title":"ACS Chem.Neurosci"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib19","unstructured":"Brouard, J.T., Herrik, K.F., De Jong, I.E., Sharp, T., In\u00a0vivo pharmacological analysis of the effects of 5-HT6 receptor ligands on cortico-raphe connectivity. Accepted abstract at the Federation of European Neurosciences Societies meeting in Copenhagen, 2-6 July 2016."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2017.07.010_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-7793.1998.117by.x","article-title":"Cholinergic activation and tonic excitation induce persistent gamma oscillations in mouse somatosensory cortex in\u00a0vitro","volume":"513","author":"Buhl","year":"1998","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-009-1701-6","article-title":"Activation of 5-HT(6) receptors facilitates attentional set shifting","volume":"208","author":"Burnham","year":"2010","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/cercor\/bhn175","article-title":"Two calretinin-positive GABAergic cell types in layer 2\/3 of the mouse neocortex provide different forms of inhibition","volume":"19","author":"Caputi","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nature08002","article-title":"Driving fast-spiking cells induces gamma rhythm and controls sensory responses","volume":"459","author":"Cardin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuron.2015.02.019","article-title":"Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5\/6(+\/-) mice","volume":"85","author":"Cho","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jalz.2006.05.2128","article-title":"5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease","volume":"2","author":"Chuang","year":"2006","journal-title":"Alzhheimers Dement."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature08573","article-title":"Frequency of gamma oscillations routes flow of information in the hippocampus","volume":"462","author":"Colgin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-510X(83)90149-1","article-title":"Monoamine metabolism in senile dementia of Alzheimer type","volume":"60","author":"Cross","year":"1983","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib28","doi-asserted-by":"crossref","first-page":"17813","DOI":"10.1523\/JNEUROSCI.3231-12.2012","article-title":"Thalamic control of layer 1 circuits in prefrontal cortex","volume":"32","author":"Cruikshank","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib29","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-385902-0.00001-2","article-title":"The central role of 5-HT6 receptors in modulating brain neurochemistry","volume":"96","author":"Dawson","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bjp.0703288","article-title":"In\u00a0vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate","volume":"130","author":"Dawson","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib32","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0893-133X(01)00265-2","article-title":"The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus","volume":"25","author":"Dawson","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nlm.2011.06.015","article-title":"Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats","volume":"96","author":"de Bruin","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nlm.2016.06.020","article-title":"The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment","volume":"133","author":"de Bruin","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-0618(97)10013-8","article-title":"Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex","volume":"14","author":"DeFelipe","year":"1997","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib36","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1523\/JNEUROSCI.17-13-05143.1997","article-title":"Synaptic connections of calretinin-immunoreactive neurons in the human neocortex","volume":"17","author":"del Rio","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000357026","article-title":"Coordinated network activity in the hippocampus","volume":"34","author":"Draguhn","year":"2014","journal-title":"Front. Neurol.Neurosci"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0166-4328(00)00261-8","article-title":"Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia","volume":"115","author":"Dringenberg","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0197-4580(00)00108-1","article-title":"Effect of tacrine on EEG slowing in the rat: enhancement by concurrent monoamine therapy","volume":"21","author":"Dringenberg","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nchembio.1547","article-title":"C.C. Mannoury la, M.J. Millan, J. Bockaert, P. Marin, S. Chaumont-Dubel, Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth","volume":"10","author":"Duhr","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/syn.10097","article-title":"5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585","volume":"45","author":"East","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1098-1063(2000)10:2<187::AID-HIPO8>3.0.CO;2-M","article-title":"Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5-2 Hz), theta (5-12 Hz), and gamma (35-70 Hz) bands","volume":"10","author":"Fellous","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40263-016-0399-3","article-title":"Serotonin 5-HT6 receptor antagonists in Alzheimer's disease: therapeutic rationale and current development status","volume":"31","author":"Ferrero","year":"2017","journal-title":"CNS.Drugs"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fphar.2017.00279","article-title":"The serotonin receptor 6 antagonist idalopirdine and acetylcholinesterase inhibitor donepezil have synergystic effects on brain activity - a functional MRI stduy in the awake rat","volume":"8","author":"Ferris","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Foley","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuropharm.2008.06.061","article-title":"An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function","volume":"55","author":"Fone","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuropharm.2016.09.017","article-title":"The 5-HT6 receptor antagonist idalopirdine potentiates the effects of donepezil on gamma oscillations in the frontal cortex of anesthetized and awake rats without affecting sleep-wake architecture","volume":"113","author":"Foraster","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib48","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/gps.934","article-title":"Glutamatergic systems in Alzheimer's disease","volume":"18","author":"Francis","year":"2003","journal-title":"Int.J.Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11590190-000000000-00000","article-title":"Role of serotonin in Alzheimer's disease: a new therapeutic target?","volume":"25","author":"Geldenhuys","year":"2011","journal-title":"CNS.Drugs"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6","article-title":"Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats","volume":"23","author":"Gerard","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0028-3908(95)00157-3","article-title":"The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex","volume":"35","author":"Giacobini","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cercor\/9.7.683","article-title":"Connectivity of GABAergic calretinin-immunoreactive neurons in rat primary visual cortex","volume":"9","author":"Gonchar","year":"1999","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib53","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1038\/srep41293","article-title":"A\u00a0new serotonin 5-HT6 receptor antagonist with procognitive activity - importance of a halogen bond interaction to stabilize the binding","volume":"7","author":"Gonzalez-Vera","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib54","first-page":"134","article-title":"Hippocampal oscillatory activity in Alzheimer's disease: toward the identification of early biomarkers?","volume":"4","author":"Goutagny","year":"2013","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/FBP.0b013e328343d804","article-title":"Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity","volume":"22","author":"Gravius","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib56","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/acschemneuro.6b00090","article-title":"Novel 1H-Pyrrolo[3,2-c]quinoline based 5-HT6 receptor antagonists with potential application for the treatment of cognitive disorders associated with Alzheimer's disease","volume":"7","author":"Grychowska","year":"2016","journal-title":"ACS Chem.Neurosci"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib57","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.neuropharm.2012.01.014","article-title":"Memantine potentiates hippocampal theta oscillations at a therapeutic dose in anesthetized mice: a mechanistic link to its cognitive-enhancing properties","volume":"62","author":"Guadagna","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1098-1063(1996)6:5<525::AID-HIPO5>3.0.CO;2-H","article-title":"Pyramidal cell dendrites are the primary targets of calbindin D28k-immunoreactive interneurons in the hippocampus","volume":"6","author":"Gulyas","year":"1996","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib59","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1523\/JNEUROSCI.16-10-03397.1996","article-title":"Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus","volume":"16","author":"Gulyas","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib60","doi-asserted-by":"crossref","first-page":"15134","DOI":"10.1523\/JNEUROSCI.4104-10.2010","article-title":"Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus","volume":"30","author":"Gulyas","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-005-2261-z","article-title":"5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats","volume":"181","author":"Hatcher","year":"2005","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-385902-0.00004-8","article-title":"The 5-HT6 receptor as a target for developing novel antiobesity drugs","volume":"96","author":"Heal","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuroscience.2015.09.064","article-title":"Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: a double in situ hybridization study","volume":"310","author":"Helboe","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib64","doi-asserted-by":"crossref","first-page":"P503","DOI":"10.1016\/j.jalz.2013.05.1046","article-title":"The 5-HT6 antagonist Lu AE58054 potentiates the effects of the acetylcholinesterase inhibitor donepezil on hippocampal extracellular acetylcholine efflux and oscillatory activity","volume":"9","author":"Herrik","year":"2013","journal-title":"Alzhheimers Dement."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2016.03.043","article-title":"The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus","volume":"107","author":"Herrik","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib66","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/mol.64.6.1295","article-title":"Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling","volume":"64","author":"Hirst","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2006.09.049","article-title":"SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models","volume":"553","author":"Hirst","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib68","unstructured":"http:\/\/files.shareholder.com\/downloads\/AMDA-GGC00\/3874732780x0x926925\/C05FC4E6-75BB-4467-881D-53786BFBE2DD\/LUNDBECK_ANNUAL_REPORT_2016.pdf."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib69","first-page":"576","article-title":"5-HT3a Receptors modulate hippocampal gamma oscillations by regulating synchrony of parvalbumin-positive interneurons","volume":"26","author":"Huang","year":"2014","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00691428","article-title":"Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia","volume":"70","author":"Ichimiya","year":"1986","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/1567205013666161108105005","article-title":"AVN-322 is a safe orally bio-available potent and highly selective antagonist of 5-HT6R with demonstrated ability to improve impaired memory in animal models","volume":"14","author":"Ivachtchenko","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib72","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3233\/JAD-2009-1008","article-title":"Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex","volume":"16","author":"Jackisch","year":"2009","journal-title":"J.\u00a0Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2006.10.006","article-title":"Correlations between acetylcholinesterase inhibition, acetylcholine levels and EEG changes during perfusion with neostigmine and N6-cyclopentyladenosine in rat brain","volume":"555","author":"Joosen","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib74","doi-asserted-by":"crossref","first-page":"12521","DOI":"10.1523\/JNEUROSCI.0640-09.2009","article-title":"Gamma-band synchronization in the macaque hippocampus and memory formation","volume":"29","author":"Jutras","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-010-1854-3","article-title":"E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat","volume":"213","author":"Kendall","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib76","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cell.2015.11.038","article-title":"Prefrontal parvalbumin neurons in control of attention","volume":"164","author":"Kim","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2004.03.012","article-title":"5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation\u2013an effect sensitive to NMDA receptor antagonism","volume":"47","author":"King","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(24)35076-1","article-title":"Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat","volume":"291","author":"Kinney","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.10288","article-title":"5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex","volume":"51","author":"Lacroix","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib80","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00001756-200207020-00021","article-title":"Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease","volume":"13","author":"Lai","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib81","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1440-1819.2005.01348.x","article-title":"Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder","volume":"59","author":"Lee","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib82","doi-asserted-by":"crossref","first-page":"16796","DOI":"10.1523\/JNEUROSCI.1869-10.2010","article-title":"The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors","volume":"30","author":"Lee","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib83","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1021\/cn500340j","article-title":"Serotonergic Regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT Receptor mechanisms and concerted effects of 5-HT Receptors exemplified by the multimodal antidepressant vortioxetine","volume":"6","author":"Leiser","year":"2015","journal-title":"ACS Chem.Neurosci"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2006.11.060","article-title":"5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus","volume":"1134","author":"Li","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib85","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.npp.1300777","article-title":"The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat","volume":"30","author":"Lieben","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib86","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.103.056002","article-title":"An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning","volume":"307","author":"Lindner","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/cn300184t","article-title":"Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation","volume":"4","author":"Ly","year":"2013","journal-title":"ACS Chem.Neurosci"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib88","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/156720510791383831","article-title":"Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease","volume":"7","author":"Maher-Edwards","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib89","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/gps.2562","article-title":"SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study","volume":"26","author":"Maher-Edwards","year":"2011","journal-title":"Int.J.Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib90","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.trci.2015.04.001","article-title":"Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease","volume":"1","author":"Maher-Edwards","year":"2015","journal-title":"Alzheimer's Dementia Transl. Res. Clin. Interventions"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib91","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0166-2236(87)90025-7","article-title":"Glutamate dysfunction in Alzheimer's disease: an hypothesis","volume":"10","author":"Maragos","year":"1987","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib92","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1460-9568.2006.05003.x","article-title":"Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release","volume":"24","author":"Marcos","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib93","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjp.2008.281","article-title":"Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat","volume":"155","author":"Marcos","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/FBP.0b013e3282ee82e3","article-title":"Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function?","volume":"18","author":"McNaughton","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib95","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/emmm.201201410","article-title":"5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia","volume":"4","author":"Meffre","year":"2012","journal-title":"EMBO Mol.Med"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-4328(00)00316-8","article-title":"Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidation","volume":"118","author":"Meneses","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib97","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1515\/revneuro-2013-0026","article-title":"5-HT systems: emergent targets for memory formation and memory alterations","volume":"24","author":"Meneses","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib98","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1515\/revneuro-2012-0060","article-title":"Serotonin and emotion, learning and memory","volume":"23","author":"Meneses","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-385902-0.00002-4","article-title":"5-HT6 receptor memory and amnesia: behavioral pharmacology\u2013learning and memory processes","volume":"96","author":"Meneses","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/WNL.58.5.828","article-title":"Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease","volume":"58","author":"Messina","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib101","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pharmthera.2005.05.001","article-title":"5-HT6 receptors: a novel target for cognitive enhancement","volume":"108","author":"Mitchell","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib102","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pbb.2007.08.015","article-title":"5-HT6 receptor antagonist reversal of emotional learning and prepulse inhibition deficits induced by apomorphine or scopolamine","volume":"88","author":"Mitchell","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib103","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-011-2518-7","article-title":"The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats","volume":"220","author":"Mohler","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib104","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(25)13616-X","article-title":"Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs","volume":"43","author":"Monsma","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2013.04.024","article-title":"The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat","volume":"249","author":"Monti","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2007.12.019","article-title":"Hippocampal interneurons co-express transcripts encoding the alpha7 nicotinic receptor subunit and the cannabinoid receptor 1","volume":"152","author":"Morales","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.02.010","article-title":"Effects of the 5-HT6 receptor antagonist idalopirdine on extracellular levels of monoamines, glutamate and acetylcholine in the rat medial prefrontal cortex","volume":"799","author":"Mork","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib108","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00711237","article-title":"Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study","volume":"12","author":"Nazarali","year":"1992","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib109","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0269881113480991","article-title":"The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats","volume":"27","author":"Nikiforuk","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/14756366.2011.595713","article-title":"Synthesis and structure-activity relationship of novel conformationally restricted analogues of serotonin as 5-HT6 receptor ligands","volume":"27","author":"Nirogi","year":"2012","journal-title":"J.Enzyme Inhib.Med.Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756366.2015.1103233","article-title":"Synthesis and biological evaluation of novel N1-phenylsulphonyl indole derivatives as potent and selective 5-HT6R ligands for the treatment of cognitive disorders","volume":"31","author":"Nirogi","year":"2016","journal-title":"J.Enzyme Inhib.Med.Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib112","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acs.jmedchem.6b01662","volume":"60","author":"Nirogi","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib113","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neubiorev.2009.12.014","article-title":"Functional role of gamma and theta oscillations in episodic memory","volume":"34","author":"Nyhus","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib114","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nature08503","article-title":"Regulation of cortical microcircuits by unitary GABA-mediated volume transmission","volume":"461","author":"Olah","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib115","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.1217276","article-title":"The cellular basis of GABA(B)-mediated interhemispheric inhibition","volume":"335","author":"Palmer","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib116","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A\u00a0network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib117","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2967\/jnumed.111.093419","article-title":"Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor","volume":"53","author":"Parker","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00200","article-title":"5-HT6 receptor agonism facilitates emotional learning","volume":"6","author":"Pereira","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.pbb.2005.05.005","article-title":"Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task","volume":"81","author":"Perez-Garcia","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib121","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.neuroscience.2006.11.003","article-title":"Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma","volume":"144","author":"Phillips","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib122","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/cercor\/bhh097","article-title":"In\u00a0vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors","volume":"14","author":"Puig","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"Raina","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/alzrt169","article-title":"5-HT6 receptors and Alzheimer's disease","volume":"5","author":"Ramirez","year":"2013","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/jn.1997.77.1.517","article-title":"Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat","volume":"77","author":"Reznic","year":"1997","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2011.04.028","article-title":"ST1936 stimulates cAMP, Ca2+, ERK1\/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors","volume":"661","author":"Riccioni","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib127","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/jm021085c","article-title":"Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist","volume":"46","author":"Riemer","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2016.04.023","article-title":"Involvement of 5-HT receptors in the action of vortioxetine in rat brain: focus on glutamatergic and GABAergic neurotransmission","volume":"108","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(02)02360-0","article-title":"The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585","volume":"934","author":"Roberts","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib130","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/sj.npp.1301654","article-title":"Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics","volume":"33","author":"Rodefer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib131","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002130100840","article-title":"5-HT6 receptor antagonists enhance retention of a water maze task in the rat","volume":"158","author":"Rogers","year":"2001","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib132","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vascn.2006.04.007","article-title":"Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells","volume":"55","author":"Romero","year":"2007","journal-title":"J.Pharmacol.Toxicol. Methods"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib133","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/oxfordjournals.bmb.a072101","article-title":"Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease","volume":"42","author":"Rossor","year":"1986","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib134","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/bbrc.1993.1619","article-title":"A\u00a0novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation","volume":"193","author":"Ruat","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dneu.20853","article-title":"Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons","volume":"71","author":"Rudy","year":"2011","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib136","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Schechter","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib137","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2174\/138161206777698909","article-title":"Serotonin and human cognitive performance","volume":"12","author":"Schmitt","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib138","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.euroneuro.2006.06.009","article-title":"Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating","volume":"17","author":"Schreiber","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib139","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainresbull.2005.12.001","article-title":"Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study","volume":"69","author":"Shearman","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0893-133X(01)00400-6","article-title":"Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat","volume":"26","author":"Shirazi-Southall","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncir.2014.00052","article-title":"mRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brain","volume":"8","author":"Shukla","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib142","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.bmcl.2009.03.077","article-title":"Synthesis and SAR of tolylamine 5-HT6 antagonists","volume":"19","author":"Singer","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib143","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0166-4328(96)00105-2","article-title":"Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides","volume":"73","author":"Sleight","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib144","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuropharm.2010.06.005","article-title":"Investigation into the efficacy of the acetylcholinesterase inhibitor, donepezil, and novel procognitive agents to induce gamma oscillations in rat hippocampal slices","volume":"59","author":"Spencer","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib145","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1523\/JNEUROSCI.15-03-02445.1995","article-title":"Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat","volume":"15","author":"Staubli","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib146","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0091-3057(01)00742-0","article-title":"Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist","volume":"71","author":"Stean","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib147","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0361-9230(99)00119-7","article-title":"Brainstem activation of thalamocortical systems","volume":"50","author":"Steriade","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib148","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0269881105056639","article-title":"A\u00a0comparison of multiple 5-HT receptors in two tasks measuring impulsivity","volume":"20","author":"Talpos","year":"2006","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib149","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1126\/science.1082053","article-title":"Identified sources and targets of slow inhibition in the neocortex","volume":"299","author":"Tamas","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimers. Dis."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib151","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuropharm.2011.05.004","article-title":"Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission","volume":"61","author":"Tassone","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib152","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2014.10.006","article-title":"Ro 04-6790-induced cognitive enhancement: no effect in trace conditioning and novel object recognition procedures in adult male Wistar rats","volume":"127","author":"Thur","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib153","first-page":"709","article-title":"Functionally relevant and functionally disruptive (epileptic) synchronized oscillations in brain slices","volume":"79","author":"Traub","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib154","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1046\/j.1460-9568.2000.00300.x","article-title":"A\u00a0model of gamma-frequency network oscillations induced in the rat CA3 region by carbachol in\u00a0vitro","volume":"12","author":"Traub","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(99)00542-X","article-title":"Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior","volume":"271","author":"Tsai","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib156","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0304-3940(99)00802-2","article-title":"Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease","volume":"276","author":"Tsai","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib157","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease","volume":"5","author":"Upton","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib158","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.neuropharm.2010.12.006","article-title":"A\u00a0microdialysis study of ST1936, a novel 5-HT6 receptor agonist","volume":"60","author":"Valentini","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib159","doi-asserted-by":"crossref","first-page":"13535","DOI":"10.1073\/pnas.1411233111","article-title":"Optogenetic activation of septal cholinergic neurons suppresses sharp wave ripples and enhances theta oscillations in the hippocampus","volume":"111","author":"Vandecasteele","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2016.04.010","article-title":"WAY208466 inhibits glutamate release at hippocampal nerve terminals","volume":"781","author":"Wang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib161","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-12-385902-0.00003-6","article-title":"Behavioral pharmacology: potential antidepressant and anxiolytic properties","volume":"96","author":"Wesolowska","year":"2011","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib162","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.neuroscience.2009.07.061","article-title":"Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus","volume":"164","author":"West","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib163","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib164","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/373612a0","article-title":"Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation","volume":"373","author":"Whittington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib165","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S1474-4422(14)70198-X","article-title":"Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"13","author":"Wilkinson","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib166","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00056-9","article-title":"A\u00a0role for 5-ht6 receptors in retention of spatial learning in the Morris water maze","volume":"41","author":"Woolley","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib167","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00213-003-1552-5","article-title":"Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790","volume":"170","author":"Woolley","year":"2003","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib168","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Woolley","year":"2004","journal-title":"Curr. Drug Targets.CNS.Neurol.Disord"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib169","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00001756-199904260-00014","article-title":"Serotonin-6 receptor variant (C267T) and clinical response to clozapine","volume":"10","author":"Yu","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.07.010_bib170","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M606215200","article-title":"The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn","volume":"282","author":"Yun","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib171","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(03)01855-7","article-title":"Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein","volume":"472","author":"Zhang","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.010_bib172","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jnr.490430116","article-title":"Effects of MF-268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex","volume":"43","author":"Zhu","year":"1996","journal-title":"J.\u00a0Neurosci. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T23:46:13Z","timestamp":1750549573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":172,"alternative-id":["S0028390817303283"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antagonism of the 5-HT6 receptor \u2013 Preclinical rationale for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}